Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation
- PMID: 16504043
- PMCID: PMC1402263
- DOI: 10.1186/1477-9560-4-4
Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation
Abstract
Disseminated intravascular coagulation (DIC) is a disorder characterized by both acute generalized, widespread activation of coagulation, which results in thrombotic complications due to the intravascular formation of fibrin, and diffuse hemorrhages, due to the consumption of platelets and coagulation factors. Systemic activation of coagulation may occur in a variety of disorders, including sepsis, severe infections, malignancies, obstetric or vascular disorders, and severe toxic or immunological reactions. In this review, we briefly report the present knowledge about the pathophysiology and diagnosis of DIC. Particular attention is also given to the current standard and experimental therapies of overt DIC.
Figures
Similar articles
-
Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update.Clin Lab. 2005;51(11-12):633-9. Clin Lab. 2005. PMID: 16329621 Review.
-
Update on the treatment of disseminated intravascular coagulation.Hematology. 2004 Apr;9(2):81-5. doi: 10.1080/1024533042000205504. Hematology. 2004. PMID: 15203862 Review.
-
Management of cancer-associated disseminated intravascular coagulation.Thromb Res. 2016 Apr;140 Suppl 1:S66-70. doi: 10.1016/S0049-3848(16)30101-3. Thromb Res. 2016. PMID: 27067981 Review.
-
Disseminated intravascular coagulation in cancer patients.Best Pract Res Clin Haematol. 2009 Mar;22(1):129-36. doi: 10.1016/j.beha.2008.12.005. Best Pract Res Clin Haematol. 2009. PMID: 19285279 Review.
-
Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.Thromb Res. 2018 Apr;164 Suppl 1:S77-S81. doi: 10.1016/j.thromres.2018.01.016. Thromb Res. 2018. PMID: 29703488
Cited by
-
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?Thromb J. 2010 May 5;8:8. doi: 10.1186/1477-9560-8-8. Thromb J. 2010. PMID: 20444280 Free PMC article.
-
Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.Thromb J. 2016 Sep 28;14:42. doi: 10.1186/s12959-016-0117-x. eCollection 2016. Thromb J. 2016. PMID: 27708553 Free PMC article. Review.
-
Therapeutic interventions in endotoxin-induced disseminated intravascular coagulation.J Nat Sci Biol Med. 2012 Jan;3(1):108-9. doi: 10.4103/0976-9668.95989. J Nat Sci Biol Med. 2012. PMID: 22690065 Free PMC article. No abstract available.
-
TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.Thromb J. 2018 Aug 11;16:20. doi: 10.1186/s12959-018-0174-4. eCollection 2018. Thromb J. 2018. PMID: 30127669 Free PMC article. Review.
-
Complexity science to conceptualize health and disease: is it relevant to clinical medicine?Mayo Clin Proc. 2012 Apr;87(4):314-9. doi: 10.1016/j.mayocp.2011.11.018. Mayo Clin Proc. 2012. PMID: 22469343 Free PMC article. Review. No abstract available.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources